164 related articles for article (PubMed ID: 28504612)
1. Changes in the albumin glycation site, plasma pentosidine and esRAGE concentrations before and after intensive diabetic treatment in patients with abnormally high glycated albumin levels.
Miyamoto H; Kohzuma T; Ohnishi A
Ann Clin Biochem; 2018 Jan; 55(1):84-91. PubMed ID: 28504612
[TBL] [Abstract][Full Text] [Related]
2. Low serum level of the endogenous secretory receptor for advanced glycation end products (esRAGE) is a risk factor for prevalent vertebral fractures independent of bone mineral density in patients with type 2 diabetes.
Yamamoto M; Yamaguchi T; Yamauchi M; Sugimoto T
Diabetes Care; 2009 Dec; 32(12):2263-8. PubMed ID: 19752174
[TBL] [Abstract][Full Text] [Related]
3. High serum pentosidine but not esRAGE is associated with prevalent fractures in type 1 diabetes independent of bone mineral density and glycaemic control.
Neumann T; Lodes S; Kästner B; Franke S; Kiehntopf M; Lehmann T; Müller UA; Wolf G; Sämann A
Osteoporos Int; 2014 May; 25(5):1527-33. PubMed ID: 24599273
[TBL] [Abstract][Full Text] [Related]
4. Increased serum endogenous secretory receptor for advanced glycation end-product (esRAGE) levels in type 2 diabetic patients with decreased renal function.
Gohda T; Tanimoto M; Moon JY; Gotoh H; Aoki T; Matsumoto M; Shibata T; Ohsawa I; Funabiki K; Tomino Y
Diabetes Res Clin Pract; 2008 Aug; 81(2):196-201. PubMed ID: 18550199
[TBL] [Abstract][Full Text] [Related]
5. Ratio of Endogenous Secretory Receptor for Advanced Glycation End Products to Pentosidine Predicts Fractures in Men.
Tamaki J; Kouda K; Fujita Y; Iki M; Yura A; Miura M; Sato Y; Okamoto N; Kurumatani N
J Clin Endocrinol Metab; 2018 Jan; 103(1):85-94. PubMed ID: 29040721
[TBL] [Abstract][Full Text] [Related]
6. The effects of n-3 long-chain polyunsaturated fatty acid supplementation on AGEs and sRAGE in type 2 diabetes mellitus.
Kurt A; Andican G; Siva ZO; Andican A; Burcak G
J Physiol Biochem; 2016 Dec; 72(4):679-687. PubMed ID: 27448155
[TBL] [Abstract][Full Text] [Related]
7. Low Endogenous Secretory Receptor for Advanced Glycation End-Products Levels Are Associated With Inflammation and Carotid Atherosclerosis in Prediabetes.
Di Pino A; Urbano F; Zagami RM; Filippello A; Di Mauro S; Piro S; Purrello F; Rabuazzo AM
J Clin Endocrinol Metab; 2016 Apr; 101(4):1701-9. PubMed ID: 26885882
[TBL] [Abstract][Full Text] [Related]
8. Soluble receptor for advanced glycation end-product (sRAGE)/pentosidine ratio: a potential risk factor determinant for type 2 diabetic retinopathy.
Ng ZX; Chua KH; Iqbal T; Kuppusamy UR
Int J Mol Sci; 2013 Apr; 14(4):7480-91. PubMed ID: 23552832
[TBL] [Abstract][Full Text] [Related]
9. Advanced Glycation End Products and esRAGE Are Associated With Bone Turnover and Incidence of Hip Fracture in Older Men.
Lamb LS; Alfonso H; Norman PE; Davis TME; Forbes J; Müench G; Irrgang F; Almeida OP; Golledge J; Hankey GJ; Flicker L; Yeap BB
J Clin Endocrinol Metab; 2018 Nov; 103(11):4224-4231. PubMed ID: 30137355
[TBL] [Abstract][Full Text] [Related]
10. Pentosidine plasma levels and relation with metabolic control in diabetic patients.
Lapolla A; Reitano R; Baccarin L; Sartore G; Plebani M; Fedele D
Horm Metab Res; 2005 Apr; 37(4):252-6. PubMed ID: 15952087
[TBL] [Abstract][Full Text] [Related]
11. Advanced glycated end-products (AGE) during haemodialysis treatment: discrepant results with different methodologies reflecting the heterogeneity of AGE compounds.
Henle T; Deppisch R; Beck W; Hergesell O; Hänsch GM; Ritz E
Nephrol Dial Transplant; 1999 Aug; 14(8):1968-75. PubMed ID: 10462279
[TBL] [Abstract][Full Text] [Related]
12. Elevated glycated albumin and reduced endogenous secretory receptor for advanced glycation endproducts levels in serum predict major adverse cardio-cerebral events in patients with type 2 diabetes and stable coronary artery disease.
Yang ZK; Shen Y; Shen WF; Pu LJ; Meng H; Zhang RY; Zhang Q; Chen QJ; De Caterina R; Lu L
Int J Cardiol; 2015 Oct; 197():241-7. PubMed ID: 26142969
[TBL] [Abstract][Full Text] [Related]
13. Increased glycated albumin and decreased esRAGE levels in serum are related to negative coronary artery remodeling in patients with type 2 diabetes: an Intravascular ultrasound study.
Du R; Zhang RY; Lu L; Shen Y; Pu LJ; Zhu ZB; Zhang Q; Hu J; Yang ZK; Ding FH; Zhang JS; Shen WF
Cardiovasc Diabetol; 2018 Nov; 17(1):149. PubMed ID: 30482197
[TBL] [Abstract][Full Text] [Related]
14. Good glycaemic control reduces oxidation and glycation end-products in collagen of diabetic rats.
Odetti P; Traverso N; Cosso L; Noberasco G; Pronzato MA; Marinari UM
Diabetologia; 1996 Dec; 39(12):1440-7. PubMed ID: 8960824
[TBL] [Abstract][Full Text] [Related]
15. Increased pentosidine, an advanced glycation end product, in plasma and synovial fluid from patients with rheumatoid arthritis and its relation with inflammatory markers.
Miyata T; Ishiguro N; Yasuda Y; Ito T; Nangaku M; Iwata H; Kurokawa K
Biochem Biophys Res Commun; 1998 Mar; 244(1):45-9. PubMed ID: 9514872
[TBL] [Abstract][Full Text] [Related]
16. Advanced glycation end products: specific fluorescence changes of pentosidine-like compounds during short daily hemodialysis.
Fagugli RM; Vanholder R; De Smet R; Selvi A; Antolini F; Lameire N; Floridi A; Buoncristiani U
Int J Artif Organs; 2001 May; 24(5):256-62. PubMed ID: 11420874
[TBL] [Abstract][Full Text] [Related]
17. Disparate changes in plasma and tissue pentosidine levels after kidney and kidney-pancreas transplantation.
Hricik DE; Wu YC; Schulak A; Friedlander MA
Clin Transplant; 1996 Dec; 10(6 Pt 1):568-73. PubMed ID: 8996781
[TBL] [Abstract][Full Text] [Related]
18. Serum pentosidine as an indicator of Alzheimer's disease.
Meli M; Perier C; Ferron C; Parssegny F; Denis C; Gonthier R; Laurent B; Reynaud E; Frey J; Chamson A
J Alzheimers Dis; 2002 Apr; 4(2):93-6. PubMed ID: 12214132
[TBL] [Abstract][Full Text] [Related]
19. Pentosidine as a biomarker for microvascular complications in type 2 diabetic patients.
Kerkeni M; Saïdi A; Bouzidi H; Letaief A; Ben Yahia S; Hammami M
Diab Vasc Dis Res; 2013 May; 10(3):239-45. PubMed ID: 23091285
[TBL] [Abstract][Full Text] [Related]
20. Elevated endogenous secretory receptor for advanced glycation end products (esRAGE) levels are associated with circulating soluble RAGE levels in diabetic children.
Saito R; Araki S; Yamamoto Y; Kusuhara K
J Pediatr Endocrinol Metab; 2017 Jan; 30(1):63-69. PubMed ID: 27941172
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
